Drug record
What four public record sets show for alprazolam. Saved Nov 10, 2026.
| Shortage | Not on the FDA shortage list | Details |
|---|---|---|
| Pharmacy cost | $0.023 each for the lowest-cost generic | Details |
| Medicare Part D, 2024 | $77.2 million | Details |
| FDA recall records | 33 | Details |
Whether the FDA lists this drug as in short supply.
The list changes daily, and it covers the national supply. A pharmacy near you can be out of a drug that is not listed, or have one that is. See today's status.
The national average price retail pharmacies pay to buy it (NADAC).
The lowest-cost generic on file is Alprazolam 0.5 Mg Tablet: pharmacies pay about $0.023 each, or $0.684 for 30.
| Product as surveyed | Type | Pharmacy pays | For 30 | Price since |
|---|---|---|---|---|
| ALPRAZOLAM 0.25 MG TABLET | Generic | $0.023 per each | $0.690 | Oct 21, 2026 |
| ALPRAZOLAM 0.5 MG TABLET | Generic | $0.023 per each | $0.684 | Oct 21, 2026 |
| ALPRAZOLAM 1 MG TABLET | Generic | $0.025 per each | $0.737 | Oct 21, 2026 |
| ALPRAZOLAM 2 MG TABLET | Generic | $0.048 per each | $1.44 | Oct 21, 2026 |
| ALPRAZOLAM ER 0.5 MG TABLET | Generic | $0.150 per each | $4.49 | Oct 21, 2026 |
| ALPRAZOLAM ER 1 MG TABLET | Generic | $0.153 per each | $4.59 | Oct 21, 2026 |
| ALPRAZOLAM ER 2 MG TABLET | Generic | $0.213 per each | $6.38 | Oct 21, 2026 |
| ALPRAZOLAM ER 3 MG TABLET | Generic | $0.247 per each | $7.42 | Oct 21, 2026 |
| ALPRAZOLAM ODT 0.25 MG TAB | Generic | $0.965 per each | $28.96 | Oct 21, 2026 |
| ALPRAZOLAM ODT 0.5 MG TAB | Generic | $1.24 per each | $37.15 | Oct 21, 2026 |
| ALPRAZOLAM ODT 1 MG TAB | Generic | $1.77 per each | $53.13 | Oct 21, 2026 |
| ALPRAZOLAM XR 0.5 MG TABLET | Generic | $0.150 per each | $4.49 | Oct 21, 2026 |
| ALPRAZOLAM XR 1 MG TABLET | Generic | $0.153 per each | $4.59 | Oct 21, 2026 |
| ALPRAZOLAM XR 2 MG TABLET | Generic | $0.213 per each | $6.38 | Oct 21, 2026 |
| ALPRAZOLAM XR 3 MG TABLET | Generic | $0.247 per each | $7.42 | Oct 21, 2026 |
| XANAX 0.25 MG TABLET | Brand | $5.63 per each | $168.84 | Oct 21, 2026 |
| XANAX 0.5 MG TABLET | Brand | $7.03 per each | $210.77 | Oct 21, 2026 |
| XANAX 1 MG TABLET | Brand | $9.35 per each | $280.46 | Oct 21, 2026 |
| XANAX 2 MG TABLET | Brand | $15.91 per each | $477.30 | Oct 21, 2026 |
This is not your price. NADAC is the national average that retail pharmacies pay to buy the drug, from the Medicaid survey for the week of Nov 11, 2026. What you pay adds the pharmacy's markup and dispensing fee and depends on your insurance or any discount card. "For 30" is shown only for products priced per tablet or capsule. Brand prices here are before any rebates.
Medicare Part D spending by product, from the latest annual file (2024).
In 2024, Medicare Part D plans and their members paid $77.2 million for the 7 products below. That is down 36% from $119.9 million in 2020.
| Product | 2024 spending | People | Per prescription | Per person, year | 2020 spending |
|---|---|---|---|---|---|
| Alprazolam Alprazolam | $60.7 million | 2,295,526 | $5.22 | $26.42 | $99.9 million |
| Xanax Alprazolam | $13.4 million | 3,271 | $660.72 | $4,088.77 | $16.6 million |
| Alprazolam ER Alprazolam | $1.8 million | 10,875 | $33.06 | $169.09 | $1.6 million |
| Alprazolam ODT Alprazolam | $563,502 | 3,612 | $63.43 | $156.01 | $632,297 |
| Alprazolam XR Alprazolam | $481,437 | 3,974 | $28.70 | $121.15 | $842,658 |
| Xanax XR Alprazolam | $222,336 | 54 | $743.60 | $4,117.34 | $316,484 |
| Alprazolam Intensol Alprazolam | $46,194 | 187 | $118.75 | $247.03 | $52,731 |
Spending is the gross amount paid at the pharmacy by Part D plans and patients, before manufacturer rebates, which can be large for brand drugs. The same person can use more than one product, so people are not added up across rows. A dash means the file suppresses a small number or has no figure for that year.
Recalls reported to the FDA that name this drug.
The FDA has 33 recall records that name alprazolam in the product description (32 Class II · 1 Class III). 4 are still marked ongoing.
Xanax XR, alprazolam, extended-release tablets, 3 mg, 60 Tablets bottles, Rx only, Distributed by: Viatris Specialty LLC, Morgantown, WV 06506, U.S.A, Made in Ireland, NDC 58151-506-91
Reason: Failed Dissolution Specifications
Alprazolam C-IV, 1 mg, packaged in a) 30 Tabs per bottle, NDC 72189-213-30; b) 60 Tabs per bottle, NDC 72189-213-60; Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534.
Reason: CGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer.
Alprazolam C-IV, 2 mg, 60 Tabs per bottle, Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534, NDC 72189-121-60.
Reason: CGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer.
Alprazolam Tab, USP 0.25mg, (CIV), 30-count bottle, Rx Only, Preferred Pharmaceuticals, Inc. Manufactured by: Breckenridge Pharmaceuticals, Inc., Boca Raton, FL. Ins:NDC 68788-7594-3
Reason: CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.
Alprazolam Tab, USP 1mg, (CIV), packaged in: a) 30-count bottle (NDC 68788-7596-3), b) 60-count bottle (NDC68788-7596-6); Rx Only, Preferred Pharmaceuticals, Inc. Manufactured by: Breckenridge Pharmaceuticals, Inc., Boca Raton, FL.
Reason: CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.
Alprazolam Tab, USP 0.5mg, (CIV), packaged in: a) 30-count bottle (NDC 68788-7595-3), b) 60-count bottle (NDC 68788-7595-6), c) 90-count bottle (NDC 68788-7595-9); Rx Only, Preferred Pharmaceuticals, Inc. Manufactured by: Breckenridge Pharmaceuticals, Inc., Boca Raton, FL.
Reason: CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.
Alprazolam C-IV, 0.5 mg, 30 Tabs per bottle, Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534, NDC 72189-0240-30.
Reason: CGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer.
Alprazolam Tablets, USP, 1 mg, CIV, packaged in: a) 100-count bottle (NDC 51991-0706-01), b) 500-count bottle (NDC 51991-0706-05) and c) 1,000-count bottle (NDC 51991-0706-10), Rx only, Manufactured by Centaur Pharmaceuticals PVT. LTD., Hinjewadi, Pune, INDIA, Distributed by: Breckenridge Pharmaceuticals, Inc., Berlin, CT 06037.
Reason: CGMP Deviations: Potential risk of Cross Contamination
Alprazolam Tablets, USP, 0.25mg, CIV, packaged in: a) 100-count bottle (NDC 51991-0704-01), b) 500-count bottle and c) 1,000-count bottle, Rx only, Manufactured by Centaur Pharmaceuticals PVT. LTD., Hinjewadi, Pune, INDIA, Distributed by: Breckenridge Pharmaceuticals, Inc., Berlin, CT 06037.
Reason: CGMP Deviations: Potential risk of Cross Contamination
Alprazolam Tablets, USP, 0.5mg, CIV, packaged in: a) 100-count bottle (NDC 51991-0705-01), b) 500-count bottle (NDC 51991-0705-05) and c) 1,000-count bottle (NDC 51991-0705-10), Rx only, Manufactured by Centaur Pharmaceuticals PVT. LTD., Hinjewadi, Pune, INDIA, Distributed by: Breckenridge Pharmaceuticals, Inc., Berlin, CT 06037.
Reason: CGMP Deviations: Potential risk of Cross Contamination
Alprazolam Tablets, USP, 2 mg, CIV, packaged in: a)100-count bottle (NDC 51991-0707-01) and b) 500-count bottle (NDC 51991-0707-05), Rx only, Manufactured by Centaur Pharmaceuticals PVT. LTD., Hinjewadi, Pune, INDIA, Distributed by: Breckenridge Pharmaceuticals, Inc., Berlin, CT 06037.
Reason: CGMP Deviations: Potential risk of Cross Contamination
Xanax XR (alprazolam) extended-release tablets, 3 mg, 60-count bottle, Rx only, Distributed by Pharmacia & Upjohn Co, Division of Fizer Inc, NY, NY 10017, NDC 0009-0068-07.
Reason: Failed Dissolution Specifications: low out of specification results for dissolution.
A recall covers specific lots from one company, not every bottle of the drug. Records include combination products and compounded versions that name this ingredient. Class I is the most serious: use could cause serious harm. Class II may cause temporary or reversible harm. Class III is unlikely to cause harm. To check a bottle, match the lot number on the label. See the live list. Do not stop a medicine because of a recall without asking your pharmacist.
These are saved records as of Nov 10, 2026; the sources update daily to yearly. For current figures open the live report for alprazolam. This page is public-record information, not medical advice.